Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

New insights in staging tools, surgical, and medical management of stage II-III melanoma

ECCO 15 - ESMO 34

Published: 23 Sep 2009

Views: 12625

Rating:

Save

Prof Alexander M. M. Eggermont, Erasmus University, Rotterdam, The Netherlands

Satellite Symposium: New Approaches in Advanced Melanoma

Official joint ECCO 15 and 34th ESMO Multidisciplinary Congress
Sponsored Satellite Symposium
Held on 20th September 2009

Categories:
Melanoma & skin

Related Videos

Assessment of suicide risk in cancer patients

Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India

Assessment of suicide risk in cancer patients ( Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India )

Cancer journeys: Research from India

Ms. Soumita Ghose - Tata Medical Center, Kolkata

Cancer journeys: Research from India ( Ms. Soumita Ghose - Tata Medical Center, Kolkata )

Depression in cancer

Ms. Bidisha Samanta - Rocket Health, Kolkata, India

Depression in cancer ( Ms. Bidisha Samanta - Rocket Health, Kolkata, India )

Managing 'fear of recurrence' of cancer patients

Ms Bincy Mathew - Manipal Hospitals, Bangalore, India

Managing 'fear of recurrence' of cancer patients ( Ms Bincy Mathew - Manipal Hospitals, Bangalore, India )

Psychological issues in familial cancer

Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India

Psychological issues in familial cancer ( Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India )

3 year follow-up shows durable long-term RFS and DMFS benefit with mRNA-4157...

Dr Meredith McKean - Sarah Cannon Research Institute, Nashville, USA

3 year follow-up shows durable long-term RFS and DMFS benefit with mRNA-4157 plus pembrolizumab in resected melanoma ( Dr Meredith McKean - Sarah Cannon Research Institute, Nashville, USA )

PD-1–refractory advanced melanoma: how do we get to the finish line?

Dr Meredith McKean - Sarah Cannon Research Institute, Nashville, USA

$PD-1–refractory advanced melanoma: how do we get to the finish line? ( Dr Meredith McKean - Sarah Cannon Research Institute, Nashville, USA )$

Highlights in melanoma from ASCO 2024

Dr Meredith McKean - Sarah Cannon Research Institute, Nashville, USA

Highlights in melanoma from ASCO 2024 ( Dr Meredith McKean - Sarah Cannon Research Institute, Nashville, USA )

Melanoma outcomes improved by dual immunotherapy before surgery rather than...

Prof Christian Blank - Netherlands Cancer Institute, Amsterdam, Netherlands

Melanoma outcomes improved by dual immunotherapy before surgery rather than after ( Prof Christian Blank - Netherlands Cancer Institute, Amsterdam, Netherlands )

More from ecancer